TransMedics Gr Q2 EPS $0.35 Beats $0.21 Estimate, Sales $114.31M Beat $98.97M Estimate
TransMedics Gr Q2 EPS $0.35 Beats $0.21 Estimate, Sales $114.31M Beat $98.97M Estimate
transmedics第二季每股收益爲0.35美元，超出了0.21美元的預估，銷售額爲1.1431億美元，超出了0.9897億美元的預估。
TransMedics Gr (NASDAQ:TMDX) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.21 by 66.67 percent. This is a 1266.67 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $114.31 million which beat the analyst consensus estimate of $98.97 million by 15.49 percent. This is a 117.87 percent increase over sales of $52.47 million the same period last year.
TransMedics Gr（納斯達克股票代碼：TMDX）報告每股盈利0.35美元，超過分析師預期的0.21美元，增長66.67％。這比去年同期每股虧損0.03美元增長了1266.67％。該公司本季度銷售額爲1,1431萬美元，超過分析師預期的9897萬美元，增長15.49％。這比去年同期銷售額爲5247萬美元增長了117.87％。